Mitochondrial dysfunction in cancer

Area of Science:

• Cell Biology
• Oncology
• Mitochondrial Biology

Background:

• Mitochondria are vital organelles responsible for cellular energy production via oxidative phosphorylation (OXPHOS) and regulate cell death and reactive oxygen species (ROS) generation.
• Mitochondria are implicated in carcinogenesis through altered energy metabolism, apoptosis resistance, increased ROS, and mitochondrial DNA (mtDNA) changes.
• Cancer cells exhibit complex metabolic strategies, often involving both glycolysis and OXPHOS, challenging traditional Warburg effect theories.

Purpose of the Study:

• To explore the multifaceted roles of mitochondria in cancer development and progression, with a specific focus on endometrial cancer.
• To investigate the significance of mitochondrial dysfunction, oxidative stress, and apoptosis regulation in various human cancers.
• To examine the potential of mitochondrial DNA alterations and BCL-2 gene expression as biomarkers for endometrial cancer.

Main Methods:

• Review of existing literature on mitochondrial function, oxidative stress, apoptosis, and their roles in carcinogenesis.
• Analysis of studies investigating metabolic profiles (glycolysis vs. OXPHOS) in tumor cells.
• Examination of data linking mitochondrial DNA mutations, ROS generation, and BCL-2 family gene expression to cancer progression, particularly in endometrial cancer.

Main Results:

• Mitochondria contribute to cancer by altering energy metabolism, promoting resistance to apoptosis, increasing ROS production, and undergoing mtDNA changes.
• Oxidative stress and chronic inflammation are linked to carcinogenesis, with conditions like inflammatory bowel disease increasing colon adenocarcinoma risk.
• In endometrial cancer, mtDNA mutations, increased mitochondrial biogenesis, and alterations in specific mitochondrial genes (MtCOI, MtND6) are observed, impacting respiratory complex assembly.
• Deregulation of apoptosis, including altered BCL-2 family gene expression, is common in many cancers, with low expression potentially indicating blocked apoptosis and correlating with aggressiveness in endometrial cancer.

Conclusions:

• Mitochondrial dysfunction and associated factors like oxidative stress and mtDNA alterations are critical drivers in cancer initiation and progression.
• The interplay between OXPHOS, glycolysis, apoptosis regulation (particularly BCL-2 family proteins), and genetic stability is central to understanding cancer biology.
• Mitochondrial biomarkers, including mtDNA mutations and BCL-2 expression levels, hold promise for predicting disease progression and aggressiveness in cancers like endometrial cancer.